FOCAL GLOMERULOSCLEROSIS side effect
What is FOCAL GLOMERULOSCLEROSIS ?Drugs associated with FOCAL GLOMERULOSCLEROSIS
CEREZYME CICLOSPORIN CYCLOPHOSPHAMIDE CYCLOSPORINE ENBREL FOSAMAX NEORAL OMNISCAN PREDNISONE PROGRAF RAPAMUNE REMICADE SIROLIMUS VALPROICFOCAL GLOMERULOSCLEROSIS : Cyclosporine Side Effects Report #5653030-6
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on Feb 27, 2008. Female patient, 56 years of age, was diagnosed with psoriasis and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, nephritis interstitial, proteinuria, . CYCLOSPORINE dosage: unknown. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Omniscan Side Effects Report #5657943-0
OMNISCAN problem was reported by a Physician from NETHERLANDS on Feb 22, 2008. Female patient, 34 years of age, weighting 94.80 lb, was diagnosed with shunt stenosis and was treated with OMNISCAN. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, scar, . OMNISCAN dosage: SEVERAL DOSES, EACH OF 20 ML, OVER A SIX-YEAR PERIOD, SINGLE DOSE. During the same period patient was treated with GANDOPENTATE DIMEGLUMINE, ARANESP, SACCHARATED IRON OXIDE, NADROPARIN, FENTANYL, DICLOFENAC, MACROGOL WITH ELECTROLYTES, PANTOPRAZOLE. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Cyclosporine Side Effects Report #5529712-3
Consumer or non-health professional from CANADA reported CYCLOSPORINE problem on Nov 19, 2007. Male patient, 26 years of age, was diagnosed with immunosuppression, nephritis interstitial, acne and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, nephropathy toxic, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with AZATHIOPRINE, PREDNISONE, SIROLIMUS, CEPHALEXIN. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Cyclosporine Side Effects Report #5476573-7
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on Sept 26, 2007. Female patient, 46 years of age, was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, thrombotic microangiopathy, . CYCLOSPORINE dosage: unknown. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Neoral Side Effects Report #5478490-5
Physician from JAPAN reported NEORAL problem on Sept 27, 2007. Female patient was diagnosed with aplastic anaemia and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, . NEORAL dosage: unknown. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Prograf Side Effects Report #5481980-2
PROGRAF problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 25, 2007. Male patient, 23 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, hyperkalaemia, renal impairment, . PROGRAF dosage: 2 MG, BID, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISONE, BACTRIM, FLUCONAZOLE, CLONIDINE, ACYCLOVIR, PEPCID. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Fosamax Side Effects Report #5485990-0
Physician from UNITED STATES reported FOSAMAX problem on Oct 09, 2007. Male patient, 48 years of age, was diagnosed with osteopenia and was treated with FOSAMAX. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, . FOSAMAX dosage: unknown. During the same period patient was treated with PREDNISONE, CELLCEPT, ENALAPRIL MALEATE, LOSARTAN POTASSIUM, TACROLIMUS. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Remicade Side Effects Report #5489200-X
REMICADE problem was reported by a Physician from UNITED STATES on Oct 08, 2007. Male patient, weighting 202.0 lb, was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, . REMICADE dosage: unknown. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Prograf Side Effects Report #5500643-8
Physician from UNITED STATES reported PROGRAF problem on Oct 10, 2007. Male patient, 48 years of age, was diagnosed with liver transplant, osteopenia and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, hyperplasia, kidney fibrosis, liver transplant rejection, osteopenia, renal tubular atrophy, renal vessel disorder, . PROGRAF dosage: ORAL; 9 MG, UID/QD, ORAL. During the same period patient was treated with CORTICOSTEROIDS, MYCOPHENOLATE MOFETIL, PREDNISONE, ALENDRONATE. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Prograf Side Effects Report #5503024-6
PROGRAF problem was reported by a Health Professional from UNITED STATES on Oct 15, 2007. Male patient, 40 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, proteinuria, . PROGRAF dosage: 2 MG, BID, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, METHYLPREDNISOLONE, PREDNISONE, ZOLOFT, ACIPHEX, SEPTRA, VALGANCICLOVIR, PROTONIX. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Sirolimus Side Effects Report #5463324-5
Health Professional from EGYPT reported SIROLIMUS problem on Sept 10, 2007. Male patient, 36 years of age, was diagnosed with diabetes mellitus and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, . SIROLIMUS dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, INSULIN, BASILIXIMAB. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Sirolimus Side Effects Report #5463325-7
SIROLIMUS problem was reported by a Health Professional from EGYPT on Sept 10, 2007. Male patient, 32 years of age, was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, . SIROLIMUS dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, BASILIXIMAB. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Sirolimus Side Effects Report #5463326-9
Health Professional from EGYPT reported SIROLIMUS problem on Sept 10, 2007. Male patient, 34 years of age, was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, . SIROLIMUS dosage: 10 MG/DAY GRADUALLY ADJUSTED TO ACHIEVE TARGET LEVEL OF 6-12 NG/ML. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, PREDNISONE, BASILIXIMAB. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Sirolimus Side Effects Report #5463331-2
SIROLIMUS problem was reported by a Health Professional from EGYPT on Sept 10, 2007. Male patient, 32 years of age, was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, . SIROLIMUS dosage: unknown. During the same period patient was treated with TACROLIMUS, PREDNISOLONE, BASILIXIMAB. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Sirolimus Side Effects Report #5463332-4
Health Professional from EGYPT reported SIROLIMUS problem on Sept 10, 2007. Female patient, 37 years of age, was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, graft complication, . SIROLIMUS dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISONE, BASILIXIMAB. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Cerezyme Side Effects Report #5413411-2
CEREZYME problem was reported by a Physician from EGYPT on July 31, 2007. Male patient, 31 years of age, weighting 94.80 lb, was diagnosed with gaucher's disease and was treated with CEREZYME. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, haemodialysis, nephritis interstitial, renal failure chronic, . CEREZYME dosage: unknown. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Sirolimus Side Effects Report #5426334-X
Physician from FRANCE reported SIROLIMUS problem on Aug 20, 2007. Female patient, 40 years of age, was diagnosed with chronic allograft nephropathy, immunosuppression and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, . SIROLIMUS dosage: unknown. During the same period patient was treated with AZATHIOPRINE. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Sirolimus Side Effects Report #5426335-1
SIROLIMUS problem was reported by a Physician from FRANCE on Aug 20, 2007. Female patient, 51 years of age, was diagnosed with chronic allograft nephropathy and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, . SIROLIMUS dosage: unknown. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Sirolimus Side Effects Report #5426336-3
Physician from FRANCE reported SIROLIMUS problem on Aug 20, 2007. Male patient, 34 years of age, was diagnosed with chronic allograft nephropathy, immunosuppression and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, . SIROLIMUS dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Sirolimus Side Effects Report #5427155-4
SIROLIMUS problem was reported by a Physician from FRANCE on Aug 20, 2007. Male patient, 29 years of age, was diagnosed with chronic allograft nephropathy, renal transplant and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, . SIROLIMUS dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Sirolimus Side Effects Report #5427156-6
Physician from FRANCE reported SIROLIMUS problem on Aug 20, 2007. Female patient, 48 years of age, was diagnosed with chronic allograft nephropathy, renal transplant and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, . SIROLIMUS dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Cyclosporine Side Effects Report #5661606-5
CYCLOSPORINE problem was reported by a Health Professional from JAPAN on Mar 07, 2008. Male patient, 56 years of age, was diagnosed with psoriasis and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, focal glomerulosclerosis, kidney fibrosis, nephritis interstitial, oedema peripheral, proteinuria, renal failure, urine protein/creatinine ratio increased, . CYCLOSPORINE dosage: unknown. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Enbrel Side Effects Report #5624497-4
Consumer or non-health professional from UNITED STATES reported ENBREL problem on Jan 30, 2008. Female patient was diagnosed with juvenile arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: contusion, focal glomerulosclerosis, glomerulonephritis, injection site pain, pyrexia, . ENBREL dosage: unknown. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Neoral Side Effects Report #5599570-X
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on Jan 16, 2008. Male patient, 60 years of age, was diagnosed with aplastic anaemia and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, focal glomerulosclerosis, low density lipoprotein apheresis, oedema, proteinuria, . NEORAL dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Neoral Side Effects Report #5557966-6
Consumer or non-health professional from JAPAN reported NEORAL problem on Dec 05, 2007. Male patient, 60 years of age, was diagnosed with aplastic anaemia and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, focal glomerulosclerosis, low density lipoprotein apheresis, oedema, proteinuria, . NEORAL dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Ciclosporin Side Effects Report #5482111-5
CICLOSPORIN problem was reported by a Consumer or non-health professional from JAPAN on Oct 03, 2007. Female patient, 46 years of age, was treated with CICLOSPORIN. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, focal glomerulosclerosis, haptoglobin decreased, proteinuria, red blood cell abnormality, thrombotic microangiopathy, . CICLOSPORIN dosage: unknown. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Neoral Side Effects Report #5486676-9
Consumer or non-health professional from JAPAN reported NEORAL problem on Oct 05, 2007. Female patient, child 10 years of age, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: body height below normal, focal glomerulosclerosis, osteonecrosis, proteinuria, renal failure acute, reversible posterior leukoencephalopathy syndrome, . NEORAL dosage: unknown. During the same period patient was treated with STEROIDS NOS, ADRENAL HORMONE PREPARATION. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Cyclosporine Side Effects Report #5487667-4
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on Oct 10, 2007. Female patient, 46 years of age, was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, focal glomerulosclerosis, haptoglobin decreased, proteinuria, red blood cell abnormality, thrombotic microangiopathy, . CYCLOSPORINE dosage: unknown. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Prednisone Side Effects Report #5488741-9
Consumer or non-health professional from reported PREDNISONE problem on Oct 10, 2007. Male patient, child 12 years of age, was diagnosed with immunosuppression, listeriosis and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: brain abscess, focal glomerulosclerosis, listeriosis, nephrotic syndrome, nuchal rigidity, pyrexia, speech disorder, tachypnoea, vomiting, . PREDNISONE dosage: unknown. During the same period patient was treated with RANITIDINE, CYCLOSPORINE, CEFTRIAXONE, ACYCLOVIR, DEXAMETHASONE, VALPROIC ACID, AMPICILLIN, AMOXICILLIN. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Prograf Side Effects Report #5490131-X
PROGRAF problem was reported by a Health Professional from UNITED STATES on Oct 02, 2007. Male patient, 23 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: dehydration, focal glomerulosclerosis, hyperkalaemia, renal impairment, . PROGRAF dosage: 2 MG, BID, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISONE, BACTRIM, FLUCONAZOLE, CLONIDINE, ACYCLOVIR, PEPCID. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Valproic Side Effects Report #5446696-7
Consumer or non-health professional from FRANCE reported VALPROIC ACID problem on Aug 28, 2007. Male patient, 35 years of age, weighting 150.8 lb, was diagnosed with epilepsy and was treated with VALPROIC ACID. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, pancreatitis, . VALPROIC ACID dosage: unknown. During the same period patient was treated with VALPROIC ACID, TICLOPIDINE HYDROCHLORIDE, ENALAPRIL. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Valproic Side Effects Report #5465654-X
VALPROIC ACID problem was reported by a Consumer or non-health professional from COTE D'IVOIRE on Sept 19, 2007. Male patient, 35 years of age, weighting 149.9 lb, was diagnosed with epilepsy and was treated with VALPROIC ACID. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, haemodialysis, . VALPROIC ACID dosage: unknown. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Cyclosporine Side Effects Report #5382556-8
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on June 27, 2007. Female patient, child 10 years of age, was diagnosed with nephrotic syndrome and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: body height below normal, focal glomerulosclerosis, osteonecrosis, proteinuria, renal failure acute, reversible posterior leukoencephalopathy syndrome, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with STEROIDS NOS. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Prograf Side Effects Report #5387640-0
PROGRAF problem was reported by a Health Professional from KOREA, REPUBLIC OF on July 02, 2007. Male patient, 13 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: disease recurrence, focal glomerulosclerosis, . PROGRAF dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Cyclosporine Side Effects Report #5382556-8
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on June 27, 2007. Female patient, child 10 years of age, was diagnosed with nephrotic syndrome and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: body height below normal, focal glomerulosclerosis, osteonecrosis, proteinuria, renal failure acute, reversible posterior leukoencephalopathy syndrome, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with STEROIDS NOS. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Prograf Side Effects Report #5387640-0
PROGRAF problem was reported by a Health Professional from KOREA, REPUBLIC OF on July 02, 2007. Male patient, 13 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: disease recurrence, focal glomerulosclerosis, . PROGRAF dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Cyclophosphamide Side Effects Report #5676269-2
Consumer or non-health professional from reported CYCLOPHOSPHAMIDE problem on Mar 17, 2008. Female patient, 16 years of age, was diagnosed with focal glomerulosclerosis, systemic lupus erythematosus, antiphospholipid syndrome, lupus nephritis and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: antiphospholipid syndrome, arterial thrombosis, focal glomerulosclerosis, myocarditis, proteinuria, stevens-johnson syndrome, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PREDNISONE, AZATHIOPRINE USP, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, RITUXIMAB, HEPARIN. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Neoral Side Effects Report #5500944-3
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on Oct 17, 2007. Female patient, 46 years of age, was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, cytomegalovirus antigen positive, focal glomerulosclerosis, haptoglobin decreased, proteinuria, red blood cell abnormality, thrombotic microangiopathy, . NEORAL dosage: unknown. During the same period patient was treated with SANDIMMUNE, CYCLOPHOSPHAMIDE, METHOTREXATE, CAMPATH, FLUDARABINE PHOSPHATE. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Neoral Side Effects Report #5501025-5
Consumer or non-health professional from JAPAN reported NEORAL problem on Oct 17, 2007. Female patient, 46 years of age, was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, cytomegalovirus antigen positive, focal glomerulosclerosis, haptoglobin decreased, proteinuria, red blood cell abnormality, thrombotic microangiopathy, . NEORAL dosage: unknown. During the same period patient was treated with SANDIMMUNE, CYCLOPHOSPHAMIDE, METHOTREXATE, CAMPATH, FLUDARABINE PHOSPHATE. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Rapamune Side Effects Report #5388906-0
RAPAMUNE problem was reported by a Physician from UNITED KINGDOM on July 12, 2007. Female patient, weighting 143.2 lb, was diagnosed with renal transplant, immunosuppression, productive cough, lower respiratory tract infection, calcium deficiency, pain and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, pneumonia, . RAPAMUNE dosage: unknown. During the same period patient was treated with CEPHALEXIN, CEFUROXIME, ERYTHROMYCIN, FRUSEMIDE, CLONAZEPAM. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Cyclosporine Side Effects Report #5388926-6
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on July 06, 2007. Male patient, child 11 years of age, was diagnosed with nephrotic syndrome and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, cytogenetic abnormality, focal glomerulosclerosis, nasopharyngitis, nephropathy, oedema, tubulointerstitial nephritis, . CYCLOSPORINE dosage: unknown. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Rapamune Side Effects Report #5388906-0
RAPAMUNE problem was reported by a Physician from UNITED KINGDOM on July 12, 2007. Female patient, weighting 143.2 lb, was diagnosed with renal transplant, immunosuppression, productive cough, lower respiratory tract infection, calcium deficiency, pain and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, pneumonia, . RAPAMUNE dosage: unknown. During the same period patient was treated with CEPHALEXIN, CEFUROXIME, ERYTHROMYCIN, FRUSEMIDE, CLONAZEPAM. Patient was hospitalized. Patient recovered.
FOCAL GLOMERULOSCLEROSIS : Cyclosporine Side Effects Report #5388926-6
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on July 06, 2007. Male patient, child 11 years of age, was diagnosed with nephrotic syndrome and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, cytogenetic abnormality, focal glomerulosclerosis, nasopharyngitis, nephropathy, oedema, tubulointerstitial nephritis, . CYCLOSPORINE dosage: unknown. Patient recovered.